MedPath

PMS-LURASIDONE

PMS-LURASIDONE

Approved
DIN Number

02505916

Drug Class

Human

Market Date

May 2, 2022

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02505916
AIG Number0153185003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AE05 LURASIDONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

LURASIDONE HYDROCHLORIDEActive
Strength: 120 MG
Monograph: LURASIDONE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.